Refining the therapeutic range of posaconazole and isavuconazole for efficient therapeutic drug monitoring using a bioassay approach-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Refining the therapeutic range of posaconazole and isavuconazole for efficient therapeutic drug monitoring using a bioassay approach

Published:2019-10-04 Issue:2 Volume:34 Page:279-287
ISSN:0767-3981
Container-title:Fundamental & Clinical Pharmacology
language:en
Short-container-title:Fundam Clin Pharmacol

Author:

Willeman Théo¹,Tonini Julia¹,Garnaud Cécile²,Bailly Sébastien³,Gandia Peggy⁴⁵,Stanke‐Labesque Françoise³,Maubon Danièle²,Gautier‐Veyret Elodie³^ORCID

Affiliation:

1. Laboratoire de Pharmacologie Pharmacogénétique et Toxicologie CHU Grenoble Alpes Grenoble France

2. CNRS CHU Grenoble Alpes Grenoble INP* TIMC‐IMAG Institute of Engineering Univ. Grenoble Alpes Univ. Grenoble Alpes 38000Grenoble France

3. Inserm CHU Grenoble Alpes Univ. Grenoble Alpes HP238000 Grenoble France

4. UMR1436‐INTHERES 31076 Toulouse France

5. Laboratoire de Pharmacocinétique et Toxicologie CHU Toulouse Toulouse France

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/fcp.12507

Reference38 articles.

1. Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease

2. Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease

3. Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis

4. Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

5. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approaches for posaconazole therapeutic drug monitoring and their clinical benefits;European Journal of Clinical Pharmacology;2024-09-09

2. Navigating Uncertainty: Managing Influenza-Associated Invasive Pulmonary Aspergillosis in an Intensive Care Unit;Journal of Fungi;2024-09-07

3. Lower blood levels of isavuconazole in critically ill patients compared with other populations: possible need for therapeutic drug monitoring;Journal of Antimicrobial Chemotherapy;2024-02-15

4. Overview of therapeutic drug monitoring and clinical practice;Talanta;2024-01

5. Population Pharmacokinetics of Isavuconazole in Critical Care Patients with COVID-19-Associated Pulmonary Aspergillosis and Monte Carlo Simulations of High Off-Label Doses;Journal of Fungi;2023-02-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3